Hypera S.A. Just Beat EPS By 8.0%: Here's What Analysts Think Will Happen Next

It's been a sad week for Hypera S.A. (BVMF:HYPE3), who've watched their investment drop 10% to R$23.19 in the week since the company reported its quarterly result. Hypera reported R$2.2b in revenue, roughly in line with analyst forecasts, although statutory earnings per share (EPS) of R$0.68 beat expectations, being 8.0% higher than what the analysts expected. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.

Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit.

Taking into account the latest results, the consensus forecast from Hypera's twelve analysts is for revenues of R$8.04b in 2025. This reflects a huge 21% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to jump 67% to R$1.97. Yet prior to the latest earnings, the analysts had been anticipated revenues of R$8.11b and earnings per share (EPS) of R$1.92 in 2025. So the consensus seems to have become somewhat more optimistic on Hypera's earnings potential following these results.

See our latest analysis for Hypera

There's been no major changes to the consensus price target of R$29.56, suggesting that the improved earnings per share outlook is not enough to have a long-term positive impact on the stock's valuation. That's not the only conclusion we can draw from this data however, as some investors also like to consider the spread in estimates when evaluating analyst price targets. There are some variant perceptions on Hypera, with the most bullish analyst valuing it at R$35.00 and the most bearish at R$25.00 per share. This shows there is still a bit of diversity in estimates, but analysts don't appear to be totally split on the stock as though it might be a success or failure situation.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. The analysts are definitely expecting Hypera's growth to accelerate, with the forecast 46% annualised growth to the end of 2025 ranking favourably alongside historical growth of 12% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 7.4% per year. Factoring in the forecast acceleration in revenue, it's pretty clear that Hypera is expected to grow much faster than its industry.

The Bottom Line

The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Hypera following these results. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. The consensus price target held steady at R$29.56, with the latest estimates not enough to have an impact on their price targets.

Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. We have forecasts for Hypera going out to 2027, and you can see them free on our platform here.

We don't want to rain on the parade too much, but we did also find 3 warning signs for Hypera (1 doesn't sit too well with us!) that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.